Sesame
-63%
est. 2Y upside i
Sesame is the first-ever healthcare marketplace, connecting thousands of healthcare providers across all 50 states directly with American consumers who are seeking high-quality, convenient medical care at half the price of what is typical.
Rank
#1754
Sector
Digital Health
Est. Liquidity
~4Y
Data Quality
Data: MediumSesame operates in a large and growing digital health market with a compelling direct-pay, transparent pricing model, evidenced by its reported high growth (nearly 500% YoY in 2022) and strong patient satisfaction (NPS 87).
Last updated: March 10, 2026
Sesame's innovative direct-pay model, particularly its successful expansion into compounded GLP-1 weight loss programs and Mental Health Rx, drives exceptional patient adoption and retention. Leveraging strategic partnerships like Costco, revenue surges to $50M+ by 2028, justifying a $480M valuation (9.6x revenue) as it captures significant market share from traditional and incumbent telehealth providers.
Sesame maintains its strong position in the cash-pay healthcare market, with steady growth in its core marketplace and moderate success in new programs like weight management and mental health. Revenue reaches $20M-$25M by 2028, leading to a $180M valuation (7.2-9x revenue) as it navigates increasing competition from larger incumbents.
Intensified competition from well-funded incumbents like Amazon One Medical and Teladoc, who aggressively expand their direct-pay offerings, significantly erodes Sesame's market share and pricing power. Regulatory headwinds concerning compounded medications further dampen growth in key segments. The company struggles to scale, leading to a down round or acquisition at a $48M valuation, severely impacting common stock value due to $84.8M in liquidation preferences.
Preference Stack Risk
severeInvestors have put in $84.8M. In a liquidation event at or below the estimated current $120M valuation, common stock (employee equity) would only see returns after the $84.8M in liquidation preferences are paid out. If the company exits at $120M, $84.8M goes to preferred shareholders, leaving $35.2M for common shareholders. If the exit is below $84.8M, common shareholders get nothing.
Dilution Risk
moderateAs a Series B company, Sesame will likely require at least one or two more significant funding rounds (Series C, D) before an IPO or acquisition, which will result in further dilution for existing common shareholders.
Secondary Liquidity
noneNo information indicates the existence of active secondary markets or tender offers for Sesame's equity.
Finance — 1 role
- Corporate Controller · New York
Last updated: March 10, 2026
Questions to Ask at the Interview
Strategic questions based on Sesame's data — designed to show you've done your homework.
- 1
“Given the aggressive entry of Amazon One Medical into the direct-pay telehealth space with competitive pricing, what specific strategies is Sesame employing to maintain its competitive differentiation and capture market share beyond its current niche?”
- 2
“With the success of the weight loss programs and Mental Health Rx, how does Sesame plan to scale these offerings while managing potential regulatory changes around compounded medications and ensuring sufficient provider capacity?”
- 3
“Considering the significant amount of capital raised ($84.8M) relative to the estimated current valuation, how does the company envision the path to a liquidity event for common shareholders, and what are the expectations for future dilution?”
Community
Valuation Sentiment
Our model estimates -63% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.